Human immunodeficiency virus (HIV), the etiologic agent of the acquired immunodeficiency syndrome (AIDS) (2, 14, 26) , is known to infect human cells which bear the CD4 surface antigen (23, 28) . Such cells include T lymphocytes (2, 14, 26) , monocytes and macrophages (15) , B lymphocytes (30) , and some cells of neuronal or glial origin (4, 8, 48) . Infection of human T lymphocytes by HIV in vitro is characterized by massive cell fusion and lysis (2, 14, 26) , whereas monocytoid cells appear to be much more resistant to virus-induced cytopathic effects (15) . Ablation of the CD4-positive T-helper subset by HIV (17) is theorized to be the principal cause of the immune defects which characterize AIDS (10, 17) . In addition, the neurological and gastrointestinal disorders observed in AIDS patients may result from direct HIV infection of cells of the brain and gut (32, 34) .
Clearly, HIV possesses a wide host cell range, which may perhaps extend in some cases to non-CD4-bearing cells (4, 39) . In vitro studies have shown that HIV isolates possess markedly different biological properties in terms of their ability to replicate and induce cytolysis in different host cell types (1, 7, 9, 24, 37, 45, 50) . However, these studies have suffered from the disadvantage that many HIV isolates contain multiple virus genotypes (38, 44) , and the observed biological effects could represent the sum of the biological properties of individual variants within a particular isolate. Furthermore, it is likely that such isolates undergo mutation or selection during isolation or propagation in cell culture. The latter is a particular cause for concern in light of the fact that immunodeficiency disease-inducing subtypes of feline leukemia viruses are replication defective and will therefore tend to be selected against during extended passage of virus-infected cells in vitro (31) . Selection of HIV subtypes with distinct cellular tropisms during virus isolation in vitro has been observed (4, 15, 24) , and new HIV variants have been derived in vitro upon prolonged culture of HIV-infected cells in the presence of anti-HIV antiserum (36) .
Understanding of the biology of HIV and its pathogenic effects would benefit from detailed analysis of single genotypic variants of the virus. Although several infectious molecular clones of HIV derived from different patients have been described (11, 25) , little attention has been paid to comparative analysis of these clones with respect to the host cell range, replicative potential, or cytopathic effects of progeny viruses. Several recent reports have demonstrated distinct biological properties of multiple HIV isolates derived from individual patients (1, 4, 5, 24, 37, 45) ; however, these viruses have not yet been cloned, and their structurefunction relationships have not been determined. In the present study, HIV type 1 (HIV-1) proviruses were cloned from cellular DNA of CEM cells infected with HIV-1/NlT virus (CEM/N1T) (3, 38) which had previously been shown to contain multiple HIV-1 genotypes (3, 8) . The activity of four progeny virus clones was assessed in a variety of cell lines, and each virus clone was found to possess distinct biological properties, including marked differences in cytopathogenicity. Our results demonstrate that HIV-1 genotypes present in an infected individual are heterogeneous both in nucleotide sequence and in biological activity.
MATERIALS AND METHODS
Cells and viruses. CD4-positive T-cell lines used in these studies were obtained as follows: CEM cells (13) (45) and by detecting HIV antigens in cells by using a fixed-cell indirect immunofluorescence assay (3) . For infection studies, cell-free supernatants from virus-producing cultures were filtered through 0.45-,um-pore-size Millex-HA filters (Millipore Corp., Bedford, Mass.); the virus was sedimented by centrifugation at 10,000 rpm for 2 h at 4°C in a JA-10 rotor (Beckman Instruments, Inc., Fullerton, Calif.), suspended in medium to give a 100-fold concentration, and tested for reverse transcriptase activity and infectivity on CEM cells. Virus preparations were then standardized to contain 100,000 cpm of reverse transcriptase activity per ml.
Preparation and analysis of cellular DNA and RNA. Cellular DNA and RNA were prepared by the cesium chlorideguanidinium isothiocyanate method (6) and analyzed by Southern (41) and Northern (RNA) blotting as described previously (3, 8) .
Molecular cloning and biological testing of HIV proviruses. Essentially, standard techniques described by Maniatis et al. (29) were followed. Approximately 6 months after initial cocultivation of patient peripheral blood lymphocytes with CEM cells, high-molecular-weight genomic DNA was isolated from NiT virus-producing cells (38) by the cesium chloride-guanidinium isothiocyanate method, digested to completion with XbaI restriction endonuclease, and size fractionated on a 10 to 40% sucrose density gradient. DNA fragments of 9 to 20 kilobases were pooled; a 0.5-,ug portion was then ligated to 0.5 ,ug of XbaI arms of XJ1 (gift of J. I. Mullins) and packaged in vitro by using Gigapack (Stratagene, La Jolla, Calif.). HIV DNA-containing bacteriophage A plaques were identified by plaque hybridization with a 32P-labeled HIV DNA probe, N1G-G (44). Twenty-one HIV-positive plaques were obtained (from a total of 3 x 106) and plaque purified three times by hybridization. Six clones (NiT-A through -F) were randomly selected for further analysis. Insert DNA was subcloned into the XbaI site of pUC18 and propagated in Escherichia coli JM109. To evaluate the biological activity of HIV-1 clones, purified plasmid DNA was transfected into adherent U-251MG cells by calcium phosphate coprecipitation (18) or into CEM cells by the DEAE-dextran method (27) . Five of the six HIV proviruses (NiT-A through -E) gave Expression of HIV-1-specific proteins in infected cells was determined by indirect immunofluorescence assay, using smears of acetone-fixed cells as described previously (3, 8) . HIV-1 replication in infected cells was determined by measuring viral reverse transcriptase activity in 50-fold-concentrated cell culture medium (3, 8) . A standard cell fixation and electron microscopy procedure (3) was used to obtain electron micrographs of the progeny HIV-1 particles produced by cells infected with the molecular clones of HIV. The viability of cells infected with HIV-1 clones was determined by the trypan blue exclusion method as described elsewhere (3, 8 Fig. 1 . Clones N1T-E and -A appeared to be the most divergent of the four, with clone N1T-E exhibiting four additional restriction sites (KpnI, PstI, HindIII, and BglII) in a 2-kilobase stretch of HIV DNA (including a 3' portion of the env gene and 5' portion of the 3' orfgene) (Fig.  1) .
Biological properties of infectious molecular clones of HIV-1. Four of the five infectious HIV DNA clones (NiT-A, -B, -D, and -E) were selected for detailed biological analysis in a variety of human cell lines. DNA from these clones was transfected into U-251MG glial cells, and virus-producing cell lines were established for each clone by adding uninfected CEM cells during culture as required. Electron microscopy and analysis of producer cell DNA and RNA by Southern and Northern blotting, respectively, confirmed that progeny viruses belonged to the HIV-1 family of viruses. An example of such a study for the CEM/N1T-A cell line is shown in Fig. 2 .
Biological experiments performed with T-lymphoid cells (CEM, HUT-78, and MT-4), cells of monocytic lineage (THP-1), and the astrocytic cell line U-251MG included evaluation of the following: ability of different clones to infect and replicate in the selected cell lines; kinetics of infection; and ability to aggregate, fuse, and lyse cells. HIV-iSF2 and the parental HIV-1/NlT strains of HIV served as biological references. The results of these studies (Table  1 , Fig. 3 ) suggest significant differences between the four clones with regard to all of the biological parameters tested. All four clones were able to infect MT-4 cells, a T-lymphoblastoid cell line carrying an HTLV-I virus genome (21) . However, the N1T-E clone required 2 weeks to establish a 50% infected state in these cells, whereas infection with N1T-A, -B, or -D was virtually completed (including marked cell fusion and cytolysis) in 3 days. CEM cells (of T-cell leukemia origin [13] ) were also susceptible to infection by all four clones, but only clone N1T-A induced significant expression of HIV antigens within 2 weeks of virus challenge (Table 1) . Clone N1T-D was markedly less efficient, whereas clones N1T-B and -E were practically incapable of causing acute infection in these cells (however, chronically infected CEM cell lines carrying these isolates could be established after 4 to 6 weeks of culture). Clones N1T-A, -B, and -E were unable to infect HUT-78 cells, a CD4-positive cell line of T-cell leukemia origin (16) , whereas infection with N1T-D was slow but eventually resulted in detectable virus antigen expression. Clones N1T-A and -B, but not -D and -E, were able to infect the monocytoid THP-1 cells, with clone N1T-A being severalfold more efficient than clone N1T-B as judged by the expression of viral antigens.
Morphological analysis of cells exposed to the various HIV-1 clones of the NiT series revealed significant differences in the ability of these clones to induce aggregation of CEM cells and to form syncytia in CEM and other cells (Table 1, Fig. 3 ). The parental strain HIV-1/NlT was most effective in aggregating CEM cells (Fig. 3e) and in inducing syncytium formation in every cell type tested except U- Fig. 3e and i) . Clone N1T-A was less effective than HIV-1/N1T in aggregating and fusing CEM cells (Fig. 3a) . Clones N1T-B and -D showed only weak cell-agglutinating activity (Fig. 3b and c) ; however, clone N1T-D, but not clone N1T-B, was able to induce low-level CEM cell fusion (Fig. 3b and c) . In contrast, both clones N1T-B and -D showed strong fusogenic activity in MT-4 cells ( Table 1 , Fig. 3f and g ). Clone NIT-E had no effect on CEM aggregation and no cytolytic or fusogenic activity in any of the cell lines tested (Table 1 , Fig. 3d and h) .
Comparison of N1T-A and N1T-E viral clones. The above data indicated that of the four infectious viral clones tested, N1T-A and NiT-E exhibited the most divergent biological properties. Subsequent analysis of the kinetics of infection and of the cytopathic effects in CEM cells exposed to N1T-A and N1T-E clones, in comparison with the parental HIV-1/ NlT virus, confirmed this finding. Clone N1T-A, similar to the parental HIV-1/NiT virus, had rapid kinetics of infection and induced massive cytolytic effects (Fig. 4) . In contrast, CEM cells exposed to N1T-E showed early signs of infection, as determined by the detection of viral antigens by immunofluorescence staining, only after 14 days from virus challenge and were fully infected, without cytopathic effects, within 3 to 4 weeks after virus exposure. Chronically infected CEM/N1T-E cells could subsequently be maintained in culture for prolonged periods of time. It is of interest that virus production in CEM/N1T-E cell lines, as measured by the presence of reverse transcriptase activity in culture supernatants, was consistently higher than in those cell lines containing replicating NiT or N1T-A virus (not shown). (19, 20, 38) and indicated that HIV isolates (which generally include multiple virus genotypes [19, 38] ) may possess different capacities for replication in various host cells (1, 4, 5, 9, 24, 37, 45, 50) . We now show that the variant molecular clones present in the original HIV-1/NlT isolate have distinguishable genomic structures and biological properties, including different host ranges, infection kinetics, replication potential, and cytopathogenicity. The parental isolate appears to represent a sum of certain of these properties (such as the combined host range of each single isolate) but masks some others (such as the low cytopathogenicity of one of the individual variants). Hence, functional analysis of any single HIV isolate must take into consideration the potential contribution (or masking) of individual variants constituting the isolate.
HIV is known to undergo rapid mutational change, particularly in the envelope gene (19, 20, 49) . Data presented here highlight this property. Restriction endonuclease mapping of the HIV-1/NlT clones indicates that there is a variation in nucleotide sequence among the different HIVs found in one infected person and that this variation is most marked in the viral env gene. Furthermore, most of the differences in restriction endonuclease patterns among NlT clones seem to be concentrated in the 3' half of the env gene (Fig. 1) , the region encoding the gp4l component of the env glycoprotein (35, 46 Fig. 3 ). This observation emphasizes the fact that presumably subtle mutational changes in HIV can lead to significant alterations in biological activity, as has been previously demonstrated for retroviruses which induce immunodeficiency in cats (32a).
Low cytopathogenicity of N1T-E clone. Among the four molecular clones of HIV-1 tested, clones N1T-A and N1T-E emerged as being the most highly divergent in their biological properties. Clone N1T-A, similar to the parental isolate, exhibited a wide host range and was highly cytopathic. Clone N1T-E induced neither giant-cell formation nor significant lysis in susceptible cells. The observed low cytopathogenicity of N1T-E was not due to limited infectivity or replication potential of this virus, as chronically infected CEM/N1T-E cell cultures were established in which most of the cells expressed HIV-1 antigens (Fig. 4A ) and which replicated N1T-E virus at the same or higher levels than did N1T-or NlT-A-producing cell lines (data not shown). This suggests that the ratio of infectious to noninfectious N1T-E viral particles may be inverted and that defective particles may predominate (which could also account for the slow kinetics of infection with this virus). An alternative possibility is suggested by the fact that the phenotype of N1T-E virus is strongly reminiscent of HIV-1 variants with a mutated or deleted sor gene (12, 42) . N1T-E virus differs from N1T-A virus in env, 3' orf, and probably other viral genes also. The possible contribution of such genomic differences to the biological properties of this virus is presently being investigated.
Implications: role of HIV variants in disease. It has been hypothesized that HIV variants may be responsible for observed differences in the manifestation of HIV-induced disease in AIDS patients (1, 5, 45) . Certainly, some HIVinfected individuals may exhibit immune deficiency in the absence of neurological damage and vice versa, and it is tempting to ascribe this to the evolution of HIV variants with particular tropism and cytopathogenicity for given cell types (34) . The rate of disease progression in AIDS may also be related to the emergence of especially pathogenic viruses (1, 45 
